Lite Strategy Inc (LITS)

$2.09 +0.15 (7.73%)
Market Cap 69.17M
Revenue (ttm) 0.00
Net Income (ttm) -15.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 866,200
Avg Vol 1,106,928
Day's Range N/A - N/A
Shares Out 35.66M
Stochastic %K 31%
Beta 0.36
Analysts Hold
Price Target N/A

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 858 369 7100
Address:
9920 Pacific Heights Blvd., Suite 150, San Diego, United States
SearchFor911
SearchFor911 Oct. 27 at 8:49 PM
$LITS https://x.com/EleanorTerrett/status/1982896424288399605 here we go 🚀 $LTC.X
1 · Reply
Red_Comet
Red_Comet Oct. 27 at 7:39 PM
$LITS nice
0 · Reply
Prometheus2
Prometheus2 Oct. 27 at 5:32 PM
$LITS - now it’s time to buy
0 · Reply
SearchFor911
SearchFor911 Oct. 27 at 4:39 PM
$LITS https://x.com/LTCFoundation/status/1982838345995784482 ETF approvals imminent. Get ready $LTC.X
1 · Reply
paul8
paul8 Oct. 27 at 4:02 PM
$ASST if you guys like this then check out $LITS Litecoin should have ETF approved next. low market cap and Saylor did say if theres another commodity like bitcoin it would be litecoin!
0 · Reply
SearchFor911
SearchFor911 Oct. 24 at 2:32 PM
$LITS something cooking here and with $LTC.X
0 · Reply
MrAlientrader
MrAlientrader Oct. 23 at 7:37 PM
$LITS massive shorts here, the short fee rate has been around 100% for several months. Shorts are not covering, they must know this company will keep dropping big
1 · Reply
soccerplayer06
soccerplayer06 Oct. 23 at 11:14 AM
$LTC.X added a little more here… again. I mean, come on, what a gift below $100 with the ETF right around the corner. It’s inevitable, and yet people are acting like it’s not gonna happen. Buy now before it’s approved! Let’s goooo. $LITS
1 · Reply
R3JS
R3JS Oct. 22 at 7:15 PM
$LITS 🔥
0 · Reply
Statistical
Statistical Oct. 22 at 3:03 PM
$LITS this company deserves a class action lawsuit after their tweeting that their price will double by end of year and it’s down 75%. Even if it doubled from here 90% of retail is still down.
2 · Reply
Latest News on LITS
MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Sep 10, 2025, 9:00 AM EDT - 6 weeks ago

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Aug 5, 2025, 8:00 AM EDT - 2 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 24, 2025, 8:00 PM EDT - 3 months ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 22, 2025, 4:35 PM EDT - 3 months ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Why Is MEI Pharma Stock Soaring On Friday?

Jul 18, 2025, 1:22 PM EDT - 3 months ago

Why Is MEI Pharma Stock Soaring On Friday?

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 8:30 AM EDT - 3 months ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

May 13, 2025, 4:05 PM EDT - 5 months ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 9 months ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Aug 12, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

MEI Pharma to Consider Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma to Consider Strategic Alternatives

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

May 14, 2024, 10:38 AM EDT - 1 year ago

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

May 9, 2024, 4:02 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:02 AM EDT - 1 year ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 11, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

Apr 10, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Mar 26, 2024, 8:00 AM EDT - 1 year ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Feb 13, 2024, 5:05 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Jan 16, 2024, 5:00 PM EST - 1 year ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

MEI Pharma Recommends Stockholders Not to Consent

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

Sep 26, 2023, 7:47 PM EDT - 2 years ago

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Aug 16, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 23, 2023, 2:30 PM EDT - 2 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 19, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

MEI Pharma Responds to Anson and Cable Car

Jul 18, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Responds to Anson and Cable Car

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 17, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

MEI Pharma Postpones Special Meeting of Shareholders

Jul 13, 2023, 4:05 PM EDT - 2 years ago

MEI Pharma Postpones Special Meeting of Shareholders

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 11, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:30 AM EDT - 2 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jul 5, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 15, 2023, 12:08 PM EDT - 2 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 14, 2023, 7:01 PM EDT - 2 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 13, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

Jun 2, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

MEI Pharma Board of Directors Rejects Unsolicited Proposal

Jun 1, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Board of Directors Rejects Unsolicited Proposal

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

May 30, 2023, 5:40 PM EDT - 2 years ago

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

SearchFor911
SearchFor911 Oct. 27 at 8:49 PM
$LITS https://x.com/EleanorTerrett/status/1982896424288399605 here we go 🚀 $LTC.X
1 · Reply
Red_Comet
Red_Comet Oct. 27 at 7:39 PM
$LITS nice
0 · Reply
Prometheus2
Prometheus2 Oct. 27 at 5:32 PM
$LITS - now it’s time to buy
0 · Reply
SearchFor911
SearchFor911 Oct. 27 at 4:39 PM
$LITS https://x.com/LTCFoundation/status/1982838345995784482 ETF approvals imminent. Get ready $LTC.X
1 · Reply
paul8
paul8 Oct. 27 at 4:02 PM
$ASST if you guys like this then check out $LITS Litecoin should have ETF approved next. low market cap and Saylor did say if theres another commodity like bitcoin it would be litecoin!
0 · Reply
SearchFor911
SearchFor911 Oct. 24 at 2:32 PM
$LITS something cooking here and with $LTC.X
0 · Reply
MrAlientrader
MrAlientrader Oct. 23 at 7:37 PM
$LITS massive shorts here, the short fee rate has been around 100% for several months. Shorts are not covering, they must know this company will keep dropping big
1 · Reply
soccerplayer06
soccerplayer06 Oct. 23 at 11:14 AM
$LTC.X added a little more here… again. I mean, come on, what a gift below $100 with the ETF right around the corner. It’s inevitable, and yet people are acting like it’s not gonna happen. Buy now before it’s approved! Let’s goooo. $LITS
1 · Reply
R3JS
R3JS Oct. 22 at 7:15 PM
$LITS 🔥
0 · Reply
Statistical
Statistical Oct. 22 at 3:03 PM
$LITS this company deserves a class action lawsuit after their tweeting that their price will double by end of year and it’s down 75%. Even if it doubled from here 90% of retail is still down.
2 · Reply
soccerplayer06
soccerplayer06 Oct. 21 at 11:21 AM
$LTC.X bought some more. gotta stack before that ETF arrives. Buying below $100 is an absolute gift. I’ll take it! $LITS
0 · Reply
soccerplayer06
soccerplayer06 Oct. 20 at 1:23 AM
$LITS $LTC.X agreed! Lite Strategy needs to make a move here. They’ve been sitting with their thumbs up their bitts since the first purchase.
0 · Reply
00DTE
00DTE Oct. 19 at 9:05 PM
$LITS these guys should put their money where their mouth is and start buying $LTC.X at these prices. People are waiting for those document filing on SEC when the govt shutdown is over.
2 · Reply
soccerplayer06
soccerplayer06 Oct. 18 at 11:09 AM
$LTC.X picked up more here. Just need to stack until that ETF comes around. It’s playing hide and seek! $LITS
0 · Reply
Patch125
Patch125 Oct. 17 at 9:02 AM
$LITS $PSQH $GNS $LITM (and more): It’s funny thst people don’t understand why certain things are diving through every support level and trendline that’s available. Because of what’s going on I’m buying as much of every position I had all along as I can. These price drops are not occurring because of the financials or technicals it’s because of what’s happening. Patience here is trusting that based on financials, technical indications and the fact that history repeats itself, that you’re not going to change your mind from the reason you bought in the first place. GLTA the patient will be a lil richer here by end of november
1 · Reply
ZiOnMuSk
ZiOnMuSk Oct. 17 at 1:11 AM
$LITS another junk
0 · Reply
CashCow11
CashCow11 Oct. 16 at 9:48 PM
$LTC.X $LITS lite strategy under $2. They are worth less than before starting the Litecoin treasury. Another Charlie Lee rug pull. Anything he touches turns to shit
1 · Reply
onemillion2012
onemillion2012 Oct. 16 at 7:29 PM
$LITS what price did Alexander schornstein pay for his shares. Any guess.?
0 · Reply
tmcThisShitEasy
tmcThisShitEasy Oct. 16 at 7:03 PM
If some $LITS and maybe some other $LYTS aren’t $LIT, you can still $LITE it up.
0 · Reply
ixzifixx
ixzifixx Oct. 16 at 6:07 PM
$LITS sharedeals.de dummies wieder fett am abstürzen ;D
1 · Reply
Statistical
Statistical Oct. 16 at 5:02 PM
$LITS bagholders who bought at 9 now need litecoin to hit 400 to make their money back for buying a company that bought litecoin at 107 and are down 80% already.
0 · Reply
Statistical
Statistical Oct. 16 at 3:59 PM
$LITS once again i will say how bulls are delusional and fell for a scam. Wait until this is under a dollar within the next month idiots
1 · Reply